"10.1371_journal.pone.0053455","plos one","2013-02-05T00:00:00Z","Sandra Okroglic; Catherine N Widmann; Horst Urbach; Philip Scheltens; Michael T Heneka","Department of Neurology, Clinical Neuroscience Unit, University of Bonn, Bonn, Germany; Department of Radiology, Neuroradiology Unit, University of Bonn, Bonn, Germany; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands","Conceived and designed the experiments: SO MTH. Performed the experiments: SO HU. Analyzed the data: SO PS MTH. Contributed reagents/materials/analysis tools: SO HU PS. Wrote the paper: SO CNW HU PS MTH.","This study had no sponsor. Funding for this study was provided by the Clinical Neuroscience Unit at the Department of Neurology, University of Bonn, Germany. S. Okroglic reports no disclosures. C.N. Widmann reports no disclosures. H. Urbach reports no disclosures. P. Scheltens serves/has served on the advisory boards of: Genentech, Novartis, Pfizer, Roche, Danone, Nutricia, Jansen AI, Baxter and Lundbeck. He has been a speaker at symposia organized by Lundbeck, Lilly, Merz, Pfizer, Jansen AI, Danone, Novartis, Roche and Genentech. He serves on the editorial board of Alzheimers Research and Therapy and Alzheimers Disease and Associated Disorders, is a member of the scientific advisory board of the EU Joint Programming Initiative and the French National Plan Alzheimer. The Alzheimer Center receives unrestricted funding from various sources through the VUmc Fonds. Dr. Scheltens receives no personal compensation for the activities mentioned above. M.T. Heneka serves on the editorial boards of the Journal of Chemical Neuroanatomy and the Journal of Neurochemistry. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Sandra Okroglic","SO",5,TRUE,2,2,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
